On Pfizer CEO Albert Bourla’s Birthday, Medical Students and Activists from Health GAP, Rise and Resist, CPD Action and More Protest at His Home to Demand Equitable Global Access to COVID-19 Vaccines
21 oct. 2021 17h12 HE | Health GAP
SCARSDALE, N.Y., Oct. 21, 2021 (GLOBE NEWSWIRE) -- On Pfizer CEO Albert Bourla’s birthday, medical students and activists held a mock celebration by placing a faux “Pfizer graveyard” outside...
KoreConX With Its All-in-One Platform Provides Infrastructure to Medical Funding Professionals
21 oct. 2021 14h00 HE | KoreConX
NEW YORK, Oct. 21, 2021 (GLOBE NEWSWIRE) --  With technology provided by KoreConX, an all-in-one platform, our KorePartners started a transformation for Life Sciences companies that are seeking to...
blue-white.png
Quris Closes Critical Drug Development Gaps With New Clinical Prediction AI Platform
18 oct. 2021 07h30 HE | Quris Technologies
BOSTON and TEL-AVIV, Israel, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today launched the first clinical prediction AI...
Picture1.jpg
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
13 oct. 2021 08h00 HE | Clearmind Medicine
TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
ibn-iw-globe-2.png
IBN (InvestorBrandNetwork) Announces Latest Episode of Stock2Me Podcast Featuring Lexaria Bioscience Corp. Chairman & CEO Chris Bunka
12 oct. 2021 08h17 HE | InvestorBrandNetwork (IBN)
LOS ANGELES, Oct. 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted communications organization engaged in connecting public companies to the investment...
member_logo_139594_45423.png
Unnatural Products Announces Research Discovery Collaboration with BridgeBio Pharma to Target Rare Diseases with Potential Oncology Applications
12 oct. 2021 08h00 HE | Unnatural Products
Santa Cruz, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech company pairing AI with parallel chemistry to create treatments for drug targets that aren’t amenable to...
CNS Pharmaceuticals logo.png
CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Dosing of First Patients in Its Berubicin Clinical Development Program for Glioblastoma Multiforme
11 oct. 2021 08h00 HE | CNS Pharmaceuticals, Inc.
LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for...
AMR Logo.png
Global Antipsychotic Drugs Market Size to Reach $26.04 Billion by 2030: Allied Market Research
07 oct. 2021 09h16 HE | Allied Market Research
Portland, OR, Oct. 07, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global antipsychotic drugs market generated $12.4 billion in 2020, and is projected...
aktana-logo.png
Aktana Launches Contextual Intelligence 360 to Solve the Challenge of Personalizing Customer Engagement at Scale
06 oct. 2021 07h26 HE | Aktana
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced Contextual Intelligence 360, a new,...
aktana-logo.png
Aktana Launches Next Generation of its Contextual Intelligence Engine to Accelerate Enterprise-Wide AI Adoption
06 oct. 2021 07h24 HE | Aktana
SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced its Contextual Intelligence Engine (CIE)...